RL
HQL

RPO LLC’s abrdn Life Sciences Investors HQL Stock Holding History

RPO LLC’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-259,275
Closed -$3.67M – 47
2024
Q2 		$3.67M Sell
259,275
-79,267
-23% -$1.07M 2.98% 11
2024
Q1 		$4.61M Hold
338,542
– – 6.63% 4
2023
Q4 		$4.56M Buy
338,542
+11,500
+4% +$141K 6.72% 3
2023
Q3 		$4.08M Buy
327,042
+140,942
+76% +$1.85M 4.6% 8
2023
Q2 		$2.52M Buy
+186,100
New +$2.57M 2.51% 11

Other funds holding HQL

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $1.03B AUM 1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $5.28B AUM 14.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

RPO LLC's HQL Position: Q3 2024 in Review

RPO LLC sold out of abrdn Life Sciences Investors (HQL) in Q3 2024, closing a stake of 259,275 shares — an estimated $3.67M sold.

RPO LLC first reported a position in HQL in Q2 2023 and held it in 5 quarters. The position peaked at $4.61M in Q1 2024. 74 funds tracked by Wall St. Rank hold HQL as of Q3 2024.

  • RPO LLC reported no remaining abrdn Life Sciences Investors position as of Q3 2024 after selling out during the quarter.
  • RPO LLC sold 259,275 abrdn Life Sciences Investors shares in Q3 2024, an estimated $3.67M.
  • RPO LLC first reported a position in abrdn Life Sciences Investors in Q2 2023 and held it in 5 quarters.
  • RPO LLC's abrdn Life Sciences Investors position peaked at $4.61M in Q1 2024.
  • 74 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2024.

Based on RPO LLC's 13F filing for Q3 2024, filed 8 Nov 2024.